BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7681292)

  • 1. Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz[a]-anthracene-induced hamster skin tumors.
    Robles AI; Gimenez-Conti IB; Roop D; Slaga TJ; Conti CJ
    Mol Carcinog; 1993; 7(2):94-8. PubMed ID: 7681292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
    Sutter C; Strickland JE; Welty DJ; Yuspa SH; Winter H; Schweizer J
    Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ras gene activation and aberrant expression of keratin K13 in ultraviolet B radiation-induced epidermal neoplasias of mouse skin.
    Sutter C; Strickland PT; Mukhtar H; Agarwal R; Winter H; Schweizer J
    Mol Carcinog; 1993; 8(1):13-9. PubMed ID: 7688967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
    Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
    Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific expression of murine keratin K13 in internal stratified squamous epithelia and its aberrant expression during two-stage mouse skin carcinogenesis is associated with the methylation state of a distinct CpG site in the remote 5'-flanking region of the gene.
    Winter H; Rentrop M; Nischt R; Schweizer J
    Differentiation; 1990 Apr; 43(2):105-14. PubMed ID: 1695590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.
    Gimenez-Conti IB; Shin DM; Bianchi AB; Roop DR; Hong WK; Conti CJ; Slaga TJ
    Cancer Res; 1990 Jul; 50(14):4441-5. PubMed ID: 1694722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early expression of type I K13 keratin in the progression of mouse skin papillomas.
    Gimenez-Conti I; Aldaz CM; Bianchi AB; Roop DR; Slaga TJ; Conti CJ
    Carcinogenesis; 1990 Nov; 11(11):1995-9. PubMed ID: 1699681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas.
    Chang KW; Lin SC; Koos S; Pather K; Solt D
    Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating mutation of the Ha-ras gene in chemically induced tumors of the hamster cheek pouch.
    Gimenez-Conti IB; Bianchi AB; Stockman SL; Conti CJ; Slaga TJ
    Mol Carcinog; 1992; 5(4):259-63. PubMed ID: 1497802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of the simple epithelial type II keratin 8 by mouse skin carcinomas but not papillomas.
    Larcher F; Bauluz C; Díaz-Guerra M; Quintanilla M; Conti CJ; Ballestín C; Jorcano JL
    Mol Carcinog; 1992; 6(2):112-21. PubMed ID: 1382441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
    Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
    Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels.
    Colapietro AM; Goodell AL; Smart RC
    Carcinogenesis; 1993 Nov; 14(11):2289-95. PubMed ID: 8242857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant in vitro expression of keratin K13 induced by Ca2+ and vitamin A acid in mouse epidermal cell lines.
    Sutter C; Nischt R; Winter H; Schweizer J
    Exp Cell Res; 1991 Jul; 195(1):183-93. PubMed ID: 1711471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
    Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
    Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters.
    Fujiki H; Suganuma M; Yoshizawa S; Kanazawa H; Sugimura T; Manam S; Kahn SM; Jiang W; Hoshina S; Weinstein IB
    Mol Carcinog; 1989; 2(4):184-7. PubMed ID: 2508660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors.
    Nelson MA; Futscher BW; Kinsella T; Wymer J; Bowden GT
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6398-402. PubMed ID: 1352887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
    Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
    Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
    French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
    Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of point mutations in murine c-Ha-ras of skin tumors initiated with dibenz[a,j]anthracene and derivatives.
    Gill RD; Beltrán L; Nettikumara AN; Harvey RG; Kootstra A; DiGiovanni J
    Mol Carcinog; 1992; 6(1):53-9. PubMed ID: 1503644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.